Dopamine D3 receptors as a therapeutic target for methamphetamine dependence (Q38173012)

30 August 2017

title

Dopamine D3 receptors as a therapeutic target for methamphetamine dependence (English)

1 reference

30 August 2017

Edythe D London

1 reference

30 August 2017

Rajkumar J Sevak

1 reference

30 August 2017

Neil E Paterson

1 reference

30 August 2017

Frank Vocci

series ordinal

1 reference

30 August 2017

Eric Wagreich

series ordinal

1 reference

30 August 2017

publication date

1 January 2014

1 reference

American Journal of Drug and Alcohol Abuse

30 August 2017

published in

1 reference

30 August 2017

1 reference

30 August 2017

1 reference

30 August 2017

page(s)

1-9

1 reference

Why do we need an Addiction supplement focused on methamphetamine?

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

National trends in psychostimulant-related deaths: 1999-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Implications of chronic methamphetamine use: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Treatments for methamphetamine abuse: a literature review for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Approaches to the development of medications for the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Medication discovery for addiction: translating the dopamine D3 receptor hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Serotonergic mechanisms in the behavioral effects of buspirone and gepirone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Neurocircuitry of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Direct and indirect interactions of the dopamine D₃ receptor with glutamate pathways: implications for the treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Dopamine D3 receptor agonists for protection and repair in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Lack of persistent changes in the dopaminergic system of rats withdrawn from methamphetamine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Altered Behavioral Response to Dopamine D3 Receptor Agonists 7-OH-DPAT and PD 128907 Following Repetitive Amphetamine Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

D(3) dopamine receptors are down-regulated in amphetamine sensitized rats and their putative antagonists modulate the locomotor sensitization to amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Disruption of nicotine conditioning by dopamine D(3) receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Detection of methamphetamine neurotoxicity in forensic autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Decreased dopamine activity predicts relapse in methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Imaging Dopamine Transmission in Cocaine Dependence: Link Between Neurochemistry and Response to Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

A Critique of Fixed and Progressive Ratio Schedules Used to Examine the Neural Substrates of Drug Reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self‐administration in rats and mice, but not in D3 receptor‐knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Effects of chronic buspirone treatment on cocaine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Occupancy of brain dopamine D3 receptors and drug craving: a translational approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Behavioral response to buspirone in cocaine and phencyclidine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

The impact of impulsivity on cocaine use and retention in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Efficacy of buspirone in alcohol dependence: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Buspirone for treatment of marijuana dependence: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

A placebo-controlled trial of buspirone for the treatment of marijuana dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Efficacy of buspirone in the treatment of opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Efficacy of buspirone in smoking cessation: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Lithium: Effects on Subjective Functioning and Morphine-Induced Euphoria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Effect of dopamine D₃ receptor antagonism on approach responses to food cues in overweight and obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952990.2013.858723

10.3109/00952990.2013.858723

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference